Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Nature Medicine
|
May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Cell
|
March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
Cell
|
April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Yanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
Cell
|
November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Rebecca P Payne, Stephanie Longet, James A Austin, et al.
Nature Communications
|
April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Cell
|
March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Wanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Nature Communications
|
March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Nature Medicine
|
May 7, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Cell
|
March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
Cell
|
April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Yanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
Cell
|
November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Rebecca P Payne, Stephanie Longet, James A Austin, et al.
Nature Communications
|
April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Cell
|
March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Wanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Nature Communications
|
March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Page
of 7